Bronchogenic carcinoma

This phase II trial is testing whether adding the immunotherapy drug atezolizumab to standard chemotherapy and radiation can help people with stage III non-small cell lung cancer that cannot be surgically removed. About 50 participants will receive the combination treatment, and …

This study followed 39 lung cancer patients who received radiation therapy to see how it affected their breathing. Researchers measured lung volume and gas exchange capacity before and after treatment, looking for a 20% or greater drop in diffusion capacity at 3 months. The goal …

This study tested whether a hospital pharmacist's interview could reduce unplanned doctor visits or hospital stays for adults with lung cancer receiving chemotherapy, immunotherapy, or oral targeted therapy. Researchers tracked 60 patients over six months, counting unscheduled co…

This study looked at whether immunotherapy for bronchial (lung) cancer can be given at home instead of in a hospital. Ten patients who were already stable on treatment received their infusions at home. Researchers tracked how many had to stop home care for medical reasons, monito…